Oxycell Facebook ad: “Hyperbaric Chamber For Sale: Oxycell HBOT Chambers”

Ran for 8 days, from February 26 to March 6, 2026, the last day Crush saw it.
Run by Oxycell on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 932210432584304
- Platforms
- Facebook, Instagram, Audience Network and Messenger
- Relaunches
- 0
Ad text
🧬 Bryan Johnson just published his HBOT results from 60 sessions — and the data is remarkable. The Blueprint founder — arguably the most measured human on the planet — completed 60 hyperbaric oxygen therapy sessions at 2 ATA with 100% oxygen via mask. Here's what happened: 🔬 Inflammation → Dropped BELOW detection limits (lowest 1%) 🩸 VEGF (new blood vessel growth) → 300% increase 🧬 Telomerase activity → Equivalent to a 12-year-old 🧠 Dementia marker (pTau217) → 28.6% reduction 🦠 Gut metabolic imbalance → Completely eliminated (score: 7 → 0) ✨ Skin age → Reversed. "Never seen a more dramatic improvement." His verdict: HBOT is "one of the highest value health therapies I've done." The protocol he used — a hard shell chamber at 2 ATA with 100% oxygen delivered via BIBS mask — is exactly the type of clinical-grade chamber we build at Oxycell. 📖 Full breakdown → https://www.oxycell.com/bryan-johnsons-hbot-results-what-60-sessions-did-to-his-body/ 🔗 oxycell.com/hyperbaric-chambers 📞 (305) 934-9660 📅 Book a consultation: calendly.com/oxycell/hbot #HBOT #HyperbaricOxygenTherapy #BryanJohnson #Blueprint #Longevity #Biohacking #AntiAging #Oxycell
Where the ad sends people
oxycell.com
Hyperbaric Chamber For Sale: Oxycell HBOT Chambers
State-of-the-art hyperbaric oxygen therapy (HBOT) chambers for your home, clinic or wellness center. Join the oxygen revolution!
Learn more: oxycell.com(opens in a new tab)







